HERTFORDSHIRE, England and
PITTSBURGH, Sept. 14, 2015 /PRNewswire/ -- Mylan N.V.
(Nasdaq: MYL), a leading global pharmaceutical company, today
announced that the Company will present at the Morgan Stanley
Global Healthcare Conference on Thursday,
Sept. 17, 2015. The presentation is scheduled to begin at
4:40 p.m. ET.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's website at
http://mylan.com/investors.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of around 1,400 generic pharmaceuticals and several brand
medications. In addition, we offer a wide range of antiretroviral
therapies, upon which nearly 50% of HIV/AIDS patients in developing
countries depend. We also operate one of the largest active
pharmaceutical ingredient manufacturers and currently market
products in about 145 countries and territories. Our workforce of
approximately 30,000 people is dedicated to creating better health
for a better world, one person at a time. Learn more at
mylan.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-morgan-stanley-global-healthcare-conference-300142248.html
SOURCE Mylan N.V.